V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005028 | 280007715 | 1.65 | 80 | Palliative (P) | 2013-01-18 | 2013-02-08 | Cisplatin + Doxorubicin | 2 | N | 280028400 | CAPECITABINE + OXALIPLATIN |
| 280005029 | 280007715 | 1.68 | 79.9 | Palliative (P) | 2016-09-06 | 2016-09-13 | Hydroxycarbamide | 2 | N | 280028400 | FLUOROURACIL |
| 280005030 | 280007715 | 1.64 | 56 | Not known (9) | 2015-09-20 | 2015-10-23 | GemCarbo Days 1+8 | N | N | 280028400 | TEMOZOLOMIDE |
| 280005031 | 280003316 | null | 79.8 | Palliative (P) | 2018-02-18 | 2018-03-16 | Y-90 | null | null | 280028405 | FCARBOST |
| 280005032 | 280003316 | 1.55 | null | Palliative (P) | 2015-04-22 | 2015-05-07 | GemCarbo Days 1+8 | N | N | 280028405 | IPILIMUMAB |
| 280005033 | 280003317 | 1.6 | 80.5 | Palliative (P) | 2016-08-16 | 2016-08-16 | Capecitabine | N | null | 280028407 | OCTREOTIDE |
| 280005034 | 280003317 | 1.81 | null | null | 2014-11-18 | 2014-12-15 | Erlotinib | N | N | 280028407 | HYDROXYCARBAMIDE |
| 280005035 | 280003317 | 1.82 | 56.5 | Palliative (P) | 2013-06-08 | 2013-06-13 | CISPLATIN + VINORELBINE | 02 | N | 280028407 | ECF |
| 280005036 | 280003317 | 1.58 | 59.6 | Neo-adjuvant (N) | null | 2015-08-07 | ECX | null | null | 280028407 | BEVACIZUMAB |
| 280005037 | 280003318 | 1.7 | 63.9 | Neo-adjuvant (N) | 2014-04-02 | 2014-04-03 | Gemcitabine weekly | N | N | 280028413 | BEVACIZUMAB |
| 280005038 | 280007718 | 1.72 | 61.2 | Neo-adjuvant (N) | 2018-05-12 | 2018-05-12 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028415 | DACARBAZINE |
| 280005039 | 280007718 | null | 116.8 | Palliative (P) | 2016-03-28 | 2016-03-29 | Paclitaxel 7 day | N | N | 280028415 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280005040 | 280003319 | 1.78 | 120 | Palliative (P) | null | 2013-04-08 | CETUXIMAB + CISPLATIN + FU | N | N | 280028417 | OCTREOTIDE |
| 280005041 | 280007719 | 1.69 | 79.6 | Disease modification (D) | null | 2013-05-16 | LIPOSOMAL DOXORUBICIN | N | N | 280028420 | IRINOTECAN + MDG |
| 280005042 | 280007719 | 1.78 | 48.7 | Adjuvant (A) | 2015-03-05 | 2015-03-25 | EW EuroEwing 99 : VIDE | N | N | 280028420 | MITOMYCIN INTRAVESICULAR |
| 280005043 | 280003320 | null | 99.8 | Palliative (P) | 2016-07-09 | 2016-07-20 | Gemcitabine + Methylprednisolone | N | N | 280028422 | OXALIPLATIN + MDG |
| 280005044 | 280003321 | 1.54 | -1 | Palliative (P) | 2013-06-10 | 2013-06-24 | IVA | N | Y | 280028423 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005045 | 280007720 | null | 80.55 | Palliative (P) | 2015-07-12 | 2015-07-14 | Docetaxel | N | N | 280028425 | MITOMYCIN INTRAVESICULAR |
| 280005046 | 280003322 | 1.8 | 75.3 | Palliative (P) | 2016-01-15 | 2016-03-10 | GemCarbo Days 1+8 | 02 | Y | 280028429 | PEMBROLIZUMAB |
| 280005047 | 280003323 | 1.67 | 0 | Disease modification (D) | 2016-03-01 | 2016-03-04 | Oxaliplatin + Modified de Gramont | 02 | N | 280028432 | CARBOPLATIN + PEMETREXED |
| 280005048 | 280003324 | 1.76 | 0 | Palliative (P) | 2017-09-20 | 2017-09-20 | GemCarbo Days 1+8 | N | N | 280028433 | OCTREOTIDE |
| 280005049 | 280003324 | null | null | Palliative (P) | 2014-04-01 | 2014-04-08 | Gemcitabine + Methylprednisolone | N | N | 280028433 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005050 | 280003324 | 1.68 | 76 | Palliative (P) | 2013-07-17 | 2013-07-18 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 280028433 | LANREOTIDE |
| 280005051 | 280003324 | 1.7 | 82.5 | Curative (C) | 2015-05-29 | 2015-07-24 | Ipilimumab | 02 | N | 280028433 | BEP |
| 280005052 | 280003325 | null | 81.9 | Adjuvant (A) | 2016-09-04 | 2016-09-23 | Oxaliplatin + Modified de Gramont | N | N | 280028444 | CAPECITABINE |
| 280005053 | 280003325 | null | null | null | null | 2015-10-22 | ECX | Y | null | 280028444 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 280005054 | 280003326 | 1.58 | 78.7 | null | 2017-05-30 | 2017-05-31 | Capecitabine | null | null | 280028448 | OCTREOTIDE |
| 280005055 | 280003326 | 1.77 | 76.5 | Curative (C) | 2013-04-11 | 2013-04-21 | IPM | N | N | 280028448 | CAPECITABINE + OXALIPLATIN |
| 280005056 | 280003327 | null | null | null | 2016-10-05 | 2016-10-05 | Cisplatin + Fluorouracil + RT 5day | N | N | 280028451 | DACARBAZINE |
| 280005057 | 280003328 | 0 | 90.7 | Palliative (P) | 2017-04-01 | 2017-04-29 | Irinotecan + Modified De Gramont | Y | Y | 280028455 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005058 | 280003328 | 0 | 38.8 | Palliative (P) | 2017-07-23 | 2017-07-23 | MITOMYCIN | N | N | 280028455 | GEMCITABINE |
| 280005059 | 280003328 | 1.72 | 107 | Palliative (P) | null | 2018-02-16 | ECX | N | N | 280028455 | OXALIPLATIN + MDG |
| 280005060 | 280003328 | 1.68 | 93.1 | Palliative (P) | 2015-09-10 | 2015-09-23 | VIDE | 02 | N | 280028455 | EPIRUBICIN |
| 280005061 | 280003329 | null | 40 | Palliative (P) | 2016-05-26 | 2016-05-29 | CARBOPLATIN + CETUXIMAB + FU | 02 | N | 280028461 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280005062 | 280007725 | 1.72 | 51.8 | Palliative (P) | 2015-06-04 | 2015-06-11 | GemCarbo Days 1+8 | N | N | 280028462 | OXALIPLATIN + MDG |
| 280005063 | 280003330 | 1.69 | 85 | null | 2017-09-11 | 2017-09-11 | GEMCARBO | 2 | N | 280028464 | CARBOPLATIN + PEMETREXED |
| 280005064 | 280003330 | 1.56 | 42.4 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-05 | Carbo F | 2 | N | 280028464 | ECX |
| 280005065 | 280003330 | 1.66 | 55.1 | Curative (C) | 2013-06-23 | 2013-06-25 | Mitomycin Intravesical | N | N | 280028464 | BENDAMUSTINE + RITUXIMAB |
| 280005066 | 280003330 | null | 71.7 | Palliative (P) | 2015-07-28 | 2015-08-12 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280028464 | IPILIMUMAB + NIVOLUMAB |
| 280005067 | 280003331 | 1.67 | 83.6 | Palliative (P) | 2016-03-07 | 2016-03-07 | VIDE | 02 | N | 280028469 | DACARBAZINE |
| 280005068 | 280007727 | 1.52 | 61 | Palliative (P) | 2016-09-24 | 2016-09-24 | ETOPOSIDE + IFOSFAMIDE | 2 | N | 280028470 | ECX |
| 280005069 | 280007727 | null | null | null | 2014-08-29 | 2014-09-10 | AFLIBERCEPT + FU + IRINOTECAN | null | null | 280028470 | GEMCITABINE |
| 280005070 | 280003332 | 1.83 | 95.15 | null | 2014-12-02 | 2014-12-18 | Cisplatin + Fluorouracil + RT 5day | N | N | 280028473 | LANREOTIDE |
| 280005071 | 280003332 | 1.78 | 74.5 | Palliative (P) | 2017-06-03 | 2017-06-12 | CAPECITABINE + CARBOPLATIN | N | N | 280028473 | OCTREOTIDE |
| 280005072 | 280003332 | null | null | null | 2017-01-31 | 2017-02-01 | Capecitabine + Mitomycin | Y | null | 280028473 | GEMCARBO |
| 280005073 | 280003332 | 1.68 | null | Palliative (P) | 2016-04-08 | 2016-04-08 | Cisplatin + Fluorouracil + RT 5day | N | null | 280028473 | FCIST |
| 280005074 | 280003333 | 1.79 | null | Palliative (P) | 2013-08-04 | 2013-08-15 | FCarboSt | 02 | N | 280028481 | GEMCITABINE |
| 280005075 | 280003333 | 1.88 | 66 | Neo-adjuvant (N) | 2015-09-26 | 2015-09-26 | EW EuroEwing 99 : VActC | N | N | 280028481 | CAPECITABINE + STREPTOZOCIN |
| 280005076 | 280003333 | 1.85 | 100.2 | null | 2016-03-12 | 2016-03-18 | IVADo | 1 | Y | 280028481 | CAPECITABINE + CARBOPLATIN |
| 280005077 | 280003334 | 1.52 | 86.4 | Palliative (P) | 2014-03-11 | 2014-03-18 | ECX | 2 | N | 280028488 | GEMCARBO |